Press releases
-
ICON awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research
ICON Wins Multiple Awards at the 2019 Clinical and Research Excellence Awards
-
ICON launches new patient engagement platform to support improved patient experience & enrolment in clinical trials
Increasing visibility of potential study participants to sites and sponsors.
-
ICON reports first quarter 2019 results
Net business wins (including pass-through) in the quarter of $885 million; a book to bill of 1.31.
-
Forbes names ICON one of the best employers in America
ICON ranked top CRO in anonymous survey of 50,000 employees across 38 sectors
-
ICON wins multiple categories in 2019 CRO Leadership Awards
ICON recognised for specialised services offering across product development lifecycle -
ICON acquires MolecularMD
ICON enhances it molecular diagnostic testing services, a key area in oncology research, with it's acquisition of MolecularMD.
-
ICON reports fourth quarter and full year 2018 results
Full year reported revenue was $2,595.8 million. Excluding the impact of ASC 606, full year revenue increased to $1,897.6 million from $1,758.4 million in 2017, an increase of 7.9%.
-
ICON launches new drug safety reporting solution ensuring compliance through automation
Developed on platform deploying rule-based automation for timely delivery of drug safety information.
-
-
